Tumor-penetrating peptide mediation: An effective strategy for improving the transport of liposomes in tumor tissue

Molecular Pharmaceutics

Volumn 11, Issue 1, 2014, Pages 218-225

  Yan, Zhiqiang ^a,b   Yang, Yiyi ^a   Wei, Xiaoli ^c   Zhong, Jian ^a   Wei, Daixu ^a   Liu, Lu ^a   Xie, Cao ^c   Wang, Fei ^c   Zhang, Lin ^c   Lu, Weiyue ^c   He, Dannong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b EAST CHINA NORMAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

doxorubicin; liposomes; targeting; transport in tumor tissue; tumor penetrating peptide

Indexed keywords

CELL PENETRATING PEPTIDE; DOXORUBICIN; LIPOSOME; TUMOR PENETRATING PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER SIZE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG DOSAGE FORM COMPARISON; DRUG PENETRATION; DRUG UPTAKE; ENCAPSULATION; FLUORESCENCE IMAGING; GROWTH INHIBITION; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; LIPOSOMAL DELIVERY; MALE; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN MODIFICATION; PROTEIN STRUCTURE; SUBCUTANEOUS TISSUE; ULTRAVIOLET SPECTROSCOPY;

ANIMALS; BIOLOGICAL TRANSPORT; CELL PROLIFERATION; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PEPTIDE FRAGMENTS; POLYETHYLENE GLYCOLS; PROSTATIC NEOPLASMS; STROMAL CELLS; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 84891758827     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400393a     Document Type: Article

References (31)

1. Farokhzad, O. C.; Langer, R. Impact of nanotechnology on drug delivery ACS Nano 2009, 3 (1) 16-20
2. Phillips, W.; Coins, B.; Medina, L. Targeting of Liposomes to Lymph Nodes. Interactions of Liposomes with the Biological Milieu; Gregoriadis, G., Ed.; Liposome Technology, Vol. III; Informa Health Care, USA, Inc.: New York, 2006; p 231
3. Yang, Y.; Yan, Z.; Zhong, J.; He, D.; Lu, W. Peptide-mediated drug delivery system for tumor targeting Prog. Chem. 2003, 25 (6) 1052-1060
4. Sugahara, K. N.; Teesalu, T.; Karmali, P. P.; Kotamraju, V. R.; Agemy, L.; Girard, O. M.; Hanahan, D.; Mattrey, R. F.; Ruoslahti, E. Tissue-penetrating delivery of compounds and nanoparticles into tumors Cancer Cell 2009, 16 (6) 510-520
5. Zhou, Y.; Kopecek, J. Biological rationale for the design of polymeric anti-cancer nanomedicines J. Drug Target. 2013, 21 (1) 1-26
6. Zhan, C.; Lu, W. The blood-brain/tumor barriers: Challenges and chances for malignant gliomas targeted drug delivery Current Pharm. Biotechnol. 2012, 13, 2380-2387
7. Padera, T. P.; Stoll, B. R.; Tooredman, J. B.; Capen, D.; di Tomaso, E.; Jain, R. K. Pathology: Cancer cells compress intratumour vessels Nature 2004, 427 (6976) 695
8. Danhier, F.; Feron, O.; Preat, V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J. Controlled Release 2010, 148 (2) 135-146
9. Minchinton, A. I.; Tannock, I. F. Drug penetration in solid tumours Nat. Rev. Cancer 2006, 6 (8) 583-592
10. Lu, W.; Xiong, C.; Zhang, R.; Shi, L.; Huang, M.; Zhang, G.; Song, S.; Huang, Q.; Liu, G. Y.; Li, C. Receptor-mediated transcytosis: a mechanism for active extravascular transport of nanoparticles in solid tumors J. Controlled Release 2012, 161 (3) 959-966
11. Hambley, T. W.; Hait, W. N. Is anticancer drug development heading in the right direction? Cancer Res. 2009, 69 (4) 1259-1262
12. Ruoslahti, E.; Bhatia, S. N.; Sailor, M. J. Targeting of drugs and nanoparticles to tumors J. Cell Biol. 2010, 188 (6) 759-768
13. Kwon, I. K.; Lee, S. C.; Han, B.; Park, K. Analysis on the current status of targeted drug delivery to tumors J. Controlled Release 2012, 164 (2) 108-114
14. Teesalu, T.; Sugahara, K. N.; Kotamraju, V. R.; Ruoslahti, E. C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (38) 16157-16162
15. Haspel, N.; Zanuy, D.; Nussinov, R.; Teesalu, T.; Ruoslahti, E.; Aleman, C. Binding of a C-end rule peptide to the neuropilin-1 receptor: A molecular modeling approach Biochemistry 2011, 50 (10) 1755-1762
16. Wild, J. R.; Staton, C. A.; Chapple, K.; Corfe, B. M. Neuropilins: expression and roles in the epithelium Int. J. Exp. Pathol. 2012, 93 (2) 81-103
17. Vanveldhuizen, P. J.; Zulfiqar, M.; Banerjee, S.; Cherian, R.; Saxena, N. K.; Rabe, A.; Thrasher, J. B.; Banerjee, S. K. Differential expression of neuropilin-1 in malignant and benign prostatic stromal tissue Oncol. Rep. 2003, 10 (5) 1067-1071
18. Osada, H.; Tokunaga, T.; Nishi, M.; Hatanaka, H.; Abe, Y.; Tsugu, A.; Kijima, H.; Yamazaki, H.; Ueyama, Y.; Nakamura, M. Overexpression of the neuropilin 1 (NRP1) gene correlated with poor prognosis in human glioma Anticancer Res. 2004, 24 (2B) 547-552
19. Sugahara, K. N.; Teesalu, T.; Karmali, P. P.; Kotamraju, V. R.; Agemy, L.; Greenwald, D. R.; Ruoslahti, E. Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs Science 2010, 328 (5981) 1031-1035
20. Ruoslahti, E. Peptides as targeting elements and tissue penetration devices for nanoparticles Adv. Mater. 2012, 24 (28) 3747-3456
21. Yan, Z.; Wang, F.; Wen, Z.; Zhan, C.; Feng, L.; Liu, Y.; Wei, X.; Xie, C.; Lu, W. LyP-1-conjugated PEGylated liposomes: A carrier system for targeted therapy of lymphatic metastatic tumor J. Controlled Release 2012, 157 (1) 118-125
22. Yan, Z.; Zhan, C.; Wen, Z.; Feng, L.; Wang, F.; Liu, Y.; Yang, X.; Dong, Q.; Liu, M.; Lu, W. LyP-1-conjugated doxorubicin-loaded liposomes suppress lymphatic metastasis by inhibiting lymph node metastases and destroying tumor lymphatics Nanotechnology 2011, 22 (41) 415103
23. Arien, A.; Dupuy, B. Encapsulation of calcitonin in liposomes depends on the vesicle preparation method J Microencapsulation 1997, 14 (6) 753-760
24. Yu, Z.; Schmaltz, R. M.; Bozeman, T. C.; Paul, R.; Rishel, M. J.; Tsosie, K. S.; Hecht, S. M. Selective tumor cell targeting by the disaccharide moiety of bleomycin J. Am. Chem. Soc. 2013, 135 (8) 2883-2886
25. Li, C.; Wang, Y.; Zhang, X.; Deng, L.; Zhang, Y.; Chen, Z. Tumor-targeted liposomal drug delivery mediated by a diseleno bond-stabilized cyclic peptide Int. J. Nanomed. 2013, 8, 1051-1062
26. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 1983, 65 (1-2) 55-63
27. Bae, Y. H. Drug targeting and tumor heterogeneity J. Controlled Release 2009, 133 (1) 2-3
28. Zhan, C.; Wei, X.; Qian, J.; Feng, L.; Zhu, J.; Lu, W. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo J. Controlled Release 2012, 160 (3) 630-636
29. Fan, Y.; Du, W.; He, B.; Fu, F.; Yuan, L.; Wu, H.; Dai, W.; Zhang, H.; Wang, X.; Wang, J.; Zhang, X.; Zhang, Q. The reduction of tumor interstitial fluid pressure by liposomal imatinib and its effect on combination therapy with liposomal doxorubicin Biomaterials 2013, 34 (9) 2277-2288
30. Beyer, I.; Li, Z.; Persson, J.; Liu, Y.; van Rensburg, R.; Yumul, R.; Zhang, X. B.; Hung, M. C.; Lieber, A. Controlled extracellular matrix degradation in breast cancer tumors improves therapy by trastuzumab Mol. Ther. 2011, 19 (3) 479-489
31. Gu, G.; Gao, X.; Hu, Q.; Kang, T.; Liu, Z.; Jiang, M.; Miao, D.; Song, Q.; Yao, L.; Tu, Y.; Pang, Z.; Chen, H.; Jiang, X.; Chen, J. The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells Biomaterials 2013, 34 (21) 5138-5148